ESTA250117P35000
- 0.80
- -0.63-44.06%
Establishment Labs Newsroom
Establishment Labs Holdings (ESTA) Gets a Hold From Citi
J.P. Morgan Maintains Establishment Labs(ESTA.US) With Buy Rating, Raises Target Price to $54
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Establishment Labs Holdings: Strong Market Acceptance and Financial Stability Drive Buy Rating
BTIG Maintains Establishment Labs(ESTA.US) With Buy Rating, Cuts Target Price to $62
Mizuho Securities Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $70
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Mizuho Securities Maintains Establishment Labs(ESTA.US) With Buy Rating, Announces Target Price $70
Establishment Labs Is Maintained at Buy by BTIG
Establishment Labs Hldgs Analyst Ratings
BTIG Maintains Establishment Labs(ESTA.US) With Buy Rating, Raises Target Price to $65
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Strong Market Potential and Solid Financial Strategy Underpin Buy Rating for Establishment Labs Holdings
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Establishment Labs Is Maintained at Neutral by Citigroup
Establishment Labs Hldgs Analyst Ratings
Citi Maintains Establishment Labs(ESTA.US) With Hold Rating, Raises Target Price to $50
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Mizuho Securities Maintains Establishment Labs(ESTA.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA), Alkermes (ALKS) and Axsome Therapeutics (AXSM)